As the driving force behind EmbryoDx Solutions, Dan Zekzer boasts 30 years of expertise in business planning, funding, partnerships, and licensing. During that time, he has collaborated with a diverse range of companies, shaping business strategies, sourcing funding, and identifying ideal strategic partnerships.

Equipped with a substantial network in the pharmaceutical industry and a multifaceted background that spans executive roles in pharma, founding a startup with a notable exit, holding an academic position at UCLA, and medical training at Yale, Dan is uniquely positioned to bridge the gap between innovative discoveries and real-world clinical applications.

Dan’s vision and expertise are pivotal in steering EmbryoDx's trajectory towards innovation.

As Scientific Adviser of EmbryoDx Solutions, Paolo brings his dual expertise in both clinical practice and research, to understand how to optimize culture conditions, identify the healthiest embryos and improve health outcomes of fetal and adult development.

​

Paolo has held various leadership roles in prestigious medical centers and research institutions, shaping the landscape of reproductive medicine through innovative clinical approaches and groundbreaking research initiatives. He has published extensively in peer-reviewed journals, presenting his findings at international conferences and symposia, thereby influencing the global discourse on reproductive health. Paolo conducts research on embryo development before implantation and the long-term consequences of in vitro culture (growth outside a living organism) at the University of California San Francisco.